Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DoseMeRx’s Bayesian precision dosing software has been clinically validated to improve patient outcomes by individualizing drug doses using real-world patient data. It has demonstrated significant reductions in adverse events such as acute kidney injury when used for vancomycin and other high-risk medications. The platform integrates with EHRs and supports compliance with AUC-guided dosing protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DoseMe.